Top compounds associated with response to SUCLA2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA semagacestat CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.1 0.0008
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.1 0.001
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.096 0.002
mRNA FK866 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA GDC-0941 FIMM pan-cancer AAC 0.61 0.002
mRNA temsirolimus FIMM pan-cancer AAC 0.53 0.002
mRNA thalidomide CTRPv2 pan-cancer AAC -0.17 0.002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV